ABBVIE EXEC SAYS WILL PRESENT LATE-STAGE DATA FOR BLOOD CANCER DRUG ETENTAMIG AT INTERNATIONAL MYELOMA SOCIETY MEETING LATER IN SEPTEMBER - CONF CALL

Reuters · 1d ago

Please log in to view news